Order Article Reprints

van der Sijde F, Homs MYV, van Bekkum ML, van den Bosch TPP, Bosscha K, Besselink MG, Bonsing BA, de Groot JWB, Karsten TM, Groot Koerkamp B, et al. Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study. International Journal of Molecular Sciences. 2021; 22(20):10902. https://doi.org/10.3390/ijms222010902

van der Sijde, Fleur, Marjolein Y. V. Homs, Marlies L. van Bekkum, Thierry P. P. van den Bosch, Koop Bosscha, Marc G. Besselink, Bert A. Bonsing, Jan Willem B. de Groot, Thomas M. Karsten, Bas Groot Koerkamp, and et al. 2021. "Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study" International Journal of Molecular Sciences 22, no. 20: 10902. https://doi.org/10.3390/ijms222010902

van der Sijde, F., Homs, M. Y. V., van Bekkum, M. L., van den Bosch, T. P. P., Bosscha, K., Besselink, M. G., Bonsing, B. A., de Groot, J. W. B., Karsten, T. M., Groot Koerkamp, B., Haberkorn, B. C. M., Luelmo, S. A. C., Mekenkamp, L. J. M., Mustafa, D. A. M., Wilmink, J. W., van Eijck, C. H. J., Vietsch, E. E., & on behalf of the Dutch Pancreatic Cancer Group. (2021). Serum miR-373-3p and miR-194-5p Are Associated with Early Tumor Progression during FOLFIRINOX Treatment in Pancreatic Cancer Patients: A Prospective Multicenter Study. International Journal of Molecular Sciences, 22(20), 10902. https://doi.org/10.3390/ijms222010902